Sun Pharma Carbidopa-Levodopa Tablets: Failed Dissolution Risk
Sun Pharma recalls 100-count and 500-count Carbidopa-Levodopa tablets (NDC 62756-519-88 and 62756-519-13) due to failed dissolution specifications. These prescription drugs may not release medication properly.
Lower-risk recall
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Sun Pharma is recalling certain Carbidopa-Levodopa tablets because they failed dissolution tests. This means the medication might not work as intended, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/42091-sun-pharma-carbidopa-levodopa-tablets-failed-dissolution-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/42091-sun-pharma-carbidopa-levodopa-tablets-failed-dissolution-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0455-2017
Cite this page
“Sun Pharma Carbidopa-Levodopa Tablets: Failed Dissolution Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42091-sun-pharma-carbidopa-levodopa-tablets-failed-dissolution-risk. Based on FDA recall #D-0455-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0455-2017%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release medication properly when taken. This could lead to inconsistent drug levels in the body, potentially reducing treatment effectiveness.
Who’s affected
Prescription drug users who have the specific 100-count or 500-count bottles with the listed NDC numbers. People taking Parkinson's disease medication are most at risk.
How to tell if you have this one
Check for 100-count bottles (NDC 62756-519-88) or 500-count bottles (NDC 62756-519-13) with expiration dates listed as JKP5530A (exp. 12/17), JKP3991A (exp. 11/17), or JKR6535A (exp. 07/18).
- Brand
Sun Pharma- Category
Drug
What to do — step by step
Check Product Details
Identify the NDC number and expiration dates on the bottle to confirm if it's part of the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Sun Pharma recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0455-2017 (January 12, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0455-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.